Overview

An Investigational Drug Study in the Treatment of Primary Dysmenorrhea (0663-064)

Status:
Completed
Trial end date:
2002-12-06
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the pain relieving effect and safety of an investigational drug in women with moderate to severe primary dysmenorrhea (painful menstruation).
Phase:
Phase 3
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Etoricoxib
Naproxen